Latest News

Blocking key enzyme minimizes stroke injury, research finds

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, research suggests. The development of a Cdk5 inhibitor as an acute neuroprotective therapy has the potential to reduce stroke injury, researchers report.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • New gadget helps vision-impaired to read graphs

  • Problem drinking in midlife doubles chance of memory problems in later life

  • Teen insomnia linked with depression, anxiety

  • Brain response to appetizing food cues varies among obese people

  • Parenting skills improve in ADHD parents with medication

  • Numerical learning disability: Dyscalculia linked to difficulties in reading and spelling

  • Sugar mimics guide stem cells toward neural fate

  • Laughter is the best medicine? The emotional appeal of stand-up comedy

  • Many depressed preschoolers still suffer in later school years

  • Naltrexone may be effective in diminishing impulse control disorders in Parkinson's disease patients

  •